New concepts in the treatment of brain tumors in very young children

References

• Milchaski A, Garrè ML. Infants Brain tumours. In: Brain and Spinal Tumours of Childhood. Walker DA, Perilongo G, Punt J, Taylor RE (Eds). Arnold Publishers, London, UK, 359–369 (2004).
   Google Scholar
• Duffner PK, Horowitz ME, Krischer JP et al. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumours. N. Engl. J. Med.328,1725–1731 (1993).
   PubMed Web of Science ®Google Scholar
• Malcon AS, Lynn A, Gloecker R. Childhood cancer: incidence, survival and mortality. In: Principles and practice of pediatric oncology. Pizzo PA and Popack DG (Eds). Lippincott, William and Wilkins, PA, USA, 1–12 (2002).
   Google Scholar
• Ries L, Smith M, Gurney JG et al. (Eds). Cancer incidence and survival among children and adolescents: United States SEER program 1975–1995. National Cancer Institute, SEER program. NHI, MD, USA (Pub N° 99–4649), 132–133; 312–313 (1999).
   Google Scholar
• Plon SE, Malkin D. Childhood cancer and heredity. In: Principles and practice of pediatric oncology. Pizzo PA, Poplack DG (Eds). Lippincott, Williams and Wilkins, PA, USA, 21–44 (2002).
   Google Scholar
• Kleihues P, Cavenee WK (Eds). World Health Organization Classification of Tumours–Pathology and Genetics of Tumours of the Nervous System. IARC Press, Lyon, France (2000).
   Google Scholar
• Packer R, Lange B, Ater J et al. Carboplatin and Vincristine for progressive low-grade gliomas of childhood. J. Neurosurg.(86), 747–754 (1997).
   PubMed Web of Science ®Google Scholar
• Grill J, Laithier V, Rodriguez D et al. When do children with optic pathway tumours need treatment? An oncological perspective in 106 patients treated at a single centre. Eur. J. Pediatr.(159), 692–696 (2000).
   PubMed Web of Science ®Google Scholar
• Amlashi SFA, Riffaud L, Brassier G, Morandi X. Nevoid basal cell carcinoma syndrome: relation with desmoplastic medulloblastoma in infancy. A population-based study and review of the literature. Cancer3(98), 618–624 (2003).
   Google Scholar
• Miyaki M, Nishio J, Konishi M et al. Drastic genetic instability of tumours and normal tissues in Turcot Syndrome. Oncogene15, 2877–2881 (1997).
   PubMed Web of Science ®Google Scholar
• Biegel JA. Cytogenetics and molecular genetics of childhood brain tumours. Neuro-oncology1,139–151 (1999).
   PubMedGoogle Scholar
• Giangaspero F, Perilongo G, Fondelli MP et al. Medulloblastoma with extensive nodularity: a variant with favourable prognosis. J. Neurosurgery91, 971–977 (1999).
   PubMed Web of Science ®Google Scholar
• Gilbertson R, Wickramasinghe C, Hernan R et al. Clinical and molecular stratification of disease risk in medulloblastoma. Br. J. Cancer85(5), 705–712 (2001).
   PubMed Web of Science ®Google Scholar
• Hasselblatt M, Bohm C, Tatenhorst L et al. Identification of novel diagnostic markers for choroid plexus tumors: a microarray-based approach. Am. J. Surg. Pathol.30(1), 66–74 (2006).
   PubMed Web of Science ®Google Scholar
• Tortori-Donati P, Rossi A, Biancheri R, Garrè ML, Cama A. Brain Tumors. In: Pediatric Neuroradiology Brain. Tortori-Donati P (Ed.). Springer Publishers, Germany 329–436 (2005).
   Google Scholar
• Kalifa C, Grill J. The therapy of infantile malignant brain tumors: current status? J. Neurooncol.75, 279–285 (2005).
   PubMed Web of Science ®Google Scholar
• Grill J, Sainte-Rose C, Jouvet A. Treatment of medulloblastoma with postoperative chemotherapy alone: an SFOP prospective trial in young children. Lancet Oncol.6(8), 573–580 (2005).
   PubMed Web of Science ®Google Scholar
• Merchant TE, Fouladi M. Ependymoma: new therapeutic approaches including radiation and chemotherapy. J. Neurooncol.75, 287–299 (2005).
   PubMed Web of Science ®Google Scholar
• Wrede B, Liu P, Ater J, Wolff JE. Second surgery and the prognosis of choroid plexus carcinoma. Results of a meta-analysis of individual cases. Anticancer Res.25(6C), 4429–4433 (2005).
   PubMed Web of Science ®Google Scholar
• Massimino M, Spreafico F, Cefalo G et al. High response rate to cisplatin/etoposide regimen in childhood low-grade glioma. J. Clin. Oncol.20(20), 4209–4216 (2002).
   PubMed Web of Science ®Google Scholar
• Prados MD, Edwards MSB, Rabbitt J et al. Treatment of pediatric low grade gliomas with a nitrosourea-based multiagent chemotherapy regimen. J. Neurooncol.32, 235–241 (1997).
   PubMed Web of Science ®Google Scholar
• Reddy A, Packer R. Chemotherapy for low grade gliomas. Childs Nerv. Syst.(15), 506–513 (1999).
   PubMed Web of Science ®Google Scholar
• Rutkowski S, Bode U, Deinlein F et al. Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N. Eng. J. Med.352(10), 978–986 (2005).
   PubMed Web of Science ®Google Scholar
• Slavc I, Schuller E, Falger J et al. Feasibility of long-term intraventricular therapy with mafosfamide (n=26) and etoposide (n=11): experience in 26 children with disseminated malignant brain tumors. J. Neurooncol.64, 239–247 (2003).
   PubMed Web of Science ®Google Scholar
• Blaney SM, Heideman R, Berg S et al. Phase I clinical trial of intrathecal topotecan in patients with neoplastic meningitis. J. Clin. Oncol.21(1), 143–147 (2003).
   PubMed Web of Science ®Google Scholar
• Lashford LS, Campbell RH, Gattamaneni HR et al. An intensive multiagent chemotherapy regimen for brain tumours occurring in very young children. Arch. Dis. Child.74, 219–223 (1996).
   PubMed Web of Science ®Google Scholar
• Finlay JL, Goldman S, Wong MC et al. Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. J. Clin. Oncol.14(9), 2495–2503 (1996).
   PubMed Web of Science ®Google Scholar
• Dunkel IJ, Finlay JL. High-dose chemotherapy with autologous stem cell rescue for brain tumors. Crit. Rev. Oncol. Hematol.41, 197–204 (2002).
   PubMed Web of Science ®Google Scholar
• Mason WP, Grovas A, Halpern S et al. Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors. J. Clin. Oncol.16(1), 210–221 (1998).
   PubMed Web of Science ®Google Scholar
• Jennings MT, Cmelak A, Johnson MD et al. Differential responsiveness among “high risk” pediatric brain tumors in a pilot study of dose-intensive induction chemotherapy. Pediatr. Blood Cancer43, 46–54 (2004).
   PubMed Web of Science ®Google Scholar
• Fagioli F, Biasin E, Mastrodicasa L et al. High-dose thiotepa and etoposide in children with poor-prognosis brain tumors. Cancer100(10), 2215–2221 (2004).
   PubMed Web of Science ®Google Scholar
• Dallorso S, Dini G, Ladenstein R et al. Evolving role of myeloablative chemotherapy in the treatment of childhood brain tumours. Bone Marrow Transplant.35(1), S31–S34 (2005).
   Google Scholar
• Broniscer A, Nicolaides TP, Dunkel IJ et al. High-dose chemotherapy with autologous stem-cell rescue in the treatment of patients with recurrent non-cerebellar primitive neuroectodermal tumors. Pediatr. Blood Cancer42, 261–267 (2004).
   PubMed Web of Science ®Google Scholar
• Dupuis-Girod S, Hartmann O, Benhamou E et al. Will high dose chemotherapy followed by autologous bone marrow transplantation supplant cranio-spinal irradiation in young children treated for medulloblastoma? J. Neuro-Oncol.27, 87–98 (1996).
   PubMed Web of Science ®Google Scholar
• Kalifa C, Valteau D, Pizer B et al. High dose chemotherapy in childhood brain tumors. Child. Nerv. Syst.15, 498–505 (1999).
   PubMed Web of Science ®Google Scholar
• Gururangan S, McLaughlin C, Quinn J et al. High-dose chemotherapy with autologous stem-cell rescue in children and adults with newly diagnosed pineoblastomas. J. Clin. Oncol.21(11), 2187–2191 (2003).
   PubMed Web of Science ®Google Scholar
• Gardner SL. Application of stem cell transplant for brain tumors. Pediatr. Transplantation8(5), 28–32 (2004).
   PubMed Web of Science ®Google Scholar
• Gleeson HK, Shalet SM. The impact of cancer therapy on the endocrine system in survivors of childhood brain tumours. Endo. Relat. Cancer11, 589–602 (2004).
   PubMed Web of Science ®Google Scholar
• Kiltie AE, Lashford LS, Gattamaneni HR. Survival and late effects in medulloblastoma patients treated with craniospinal irradiation under three years old. Med. Pediatr. Oncol.28, 348–354 (1997).
   PubMedGoogle Scholar
• Grill J, Renaux VK, Bulteau C et al. Long-term intellectual outcome in children with posterior fossa tumors according to radiation doses and volumes. Intl J. Radiat. Oncol. Biol. Phys.45, 137–145 (1999).
   PubMed Web of Science ®Google Scholar
• Mulhern RK, Palmer SL, Merchant TE et al. Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma. J. Clin. Oncol.23(24), 5511–5519 (2005).
   PubMed Web of Science ®Google Scholar
• Merchant TE, Mulhern RK, Krasin MJ et al. Preliminary results from a Phase II trial of conformal radiation therapy and evaluation of radiation-related cns effects for pediatric patients with localized ependymoma. J. Clin. Oncol.22(15), 3156–3162 (2004).
   PubMed Web of Science ®Google Scholar
• Lee CT, Bilton SD, Famiglietti RM et al. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques? Int. J. Radiat. Oncol. Biol. Phys.63(2), 362–372 (2005).
   PubMed Web of Science ®Google Scholar
• Tenreiro-Picon OR, Kamath SV, Knorr JR et al. Desmoplastic infantile ganglioglioma: CT and MRI features. Pediatr. Radiol.25, 540–543 (1995).
   PubMed Web of Science ®Google Scholar
• Garrè ML, El-Hossainy MO, Fondelli P et al. Is chemotherapy effective therapy for intracranial immature teratoma. Cancer77, 977–982 (1996).
   PubMed Web of Science ®Google Scholar
• Ferreira J, Eviatar L, Schneider S, Grossman R. Prenatal diagnosis of intracranial teratoma. Prolonged survival after resection of a malignant teratoma diagnosed prenatally by ultrasound: a case report and review of literature. Pediatr. Neurosurg.19, 84–88 (1993).
   PubMed Web of Science ®Google Scholar
• Pencalet P, Sainte-Rose C, Lellouch-Tubiana A et al. Papillomas and carcinomas of the choroid plexus in children. J. Neurosurg.88, 521–528 (1998).
   PubMed Web of Science ®Google Scholar
• Berger C, Thiesse P, Lellouch-Tubiana A et al. Choroid plexus carcinomas in childhood: clinical features and prognostic factors. Neurosurgery42(3), 470–475 (1998).
   PubMed Web of Science ®Google Scholar
• Mc Evoy AW, Harding BN, Phipps KP et al. Management of choroid plexus tumours in children: 20 years experience at a single neurosurgical centre. Pediatr. Neurosurg.32(4), 192–199 (2000).
   PubMed Web of Science ®Google Scholar
• Garrè ML, Brisigotti M, Capra V et al. Frequency and biological behaviour of choroid plexus (CP) tumours in children. Neurooncology2(1), 275–280 (2000).
   Google Scholar
• Allen J. Initial management of children with hypothalamic and thalamic tumors and the modifyng role of neurofibromatosis-1. Paediatr. Neurosurg.(32), 154–162 (2000).
   PubMed Web of Science ®Google Scholar
• Tihan T, Burger PC. A variant of pylocitic astrocytoma a possible distinct clinicopathological entity with a less favourable outcome. J. Neuropathol. Exp. Neurol.57, 495–500 (1998).
   Google Scholar
• Ater JL, Van Eys J, Woo SY et al. MOPP chemotherapy without irradiation as primary post-surgical therapy for brain tumors in infants and young children. J. Neurooncol.32, 243–252 (1997).
   PubMed Web of Science ®Google Scholar
• Duffner PK, Horowitz ME, Krischer JP et al. The treatment of malignant brain tumours in infants and very young children: an update of the Pediatric Oncology Group experience. Neurooncology1(2), 152–161 (1999).
   PubMedGoogle Scholar
• Geyer JR, Sposto R, Jennings M et al. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the children’s cancer group. J. Clin. Oncol.23(30), 7621–7631 (2005).
   PubMed Web of Science ®Google Scholar
• Marec-Berard P, Jouvet A, Thiesse P et al. Supratentorial embryonal tumours in children under 5 years an SFOP study of treatment with postoperative chemotherapy alone. Med. Pediatr. Oncol.38(2), 83–90 (2002).
   PubMedGoogle Scholar
• Garrè ML, Massimino M, Cefalo G et al. High-risk malignant CNS tumours in infants: standard vs mieloablative chemotherapy: the experience of the Italian cooperative study for children <3 years of age. Neurooncology1(5), 40–50 (2003).
   Google Scholar
• Becker LE, Cruz-Sanchez. Ependymoblastoma in Pathology and Genetics of Tumours of the nervous system. Kleihaues, Cavenee WK (Eds). IARC Press, Lyon, France (2000).
   Google Scholar
• Massimino M, Gandola L, Giangaspero F et al. Hyperfractionated radiotherapy and chemotherapy for childhood ependymoma: final results of the first prospective AIEOP (Associazione Italiana di Emato-Oncologia Pediatrica) study. Int. J. Radiat. Oncol. Biol. Phys.58(5), 1336–1345 (2004).
   PubMed Web of Science ®Google Scholar
• Agaoglu FY, Ayan I, Dizdar Y et al. Ependymal tumors in childhood. Pediatr. Blood Cancer45, 298–303 (2005).
   PubMed Web of Science ®Google Scholar
• Grill J, Le Deley M, Gambarelli D et al. Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology. J. Clin. Oncol.19(5), 1288–1296 (2001).
   PubMed Web of Science ®Google Scholar
• Rorke LB Packer RJ Biegel JA. Central nervous system atypical teratoid/rhabdoid tumours of infancy and childhood definition of an entity. J. Neurosurg.85, 56–65 (1996).
   PubMed Web of Science ®Google Scholar
• Burger PC, Yu IT, Friedman HS et al. Atypical teratoid/rhabdoid tumour of the central nervous system. A highly malignant tumour of infancy and childhood frequently mistaken for medulloblastoma. A Paediatric Oncology Group Study. Am. J. Surg. Pathol.22, 1083–1092 (1998).
   PubMed Web of Science ®Google Scholar
• Taylor MD, Gokgoz N, Andrulis IL et al. Familial posterior fossa brain tumours of infancy secondary to germiline mutation of the hSNF5 gene. Am. J. Hum. Genet.66, 1403–1406 (2000).
   PubMed Web of Science ®Google Scholar
• Tortori-Donati P, Fondelli MP, Rossi A et al. Atypical teratoid rhabdoid tumours of the central nervous system in infancy – neuroradiological findings. Int. J. Neuroradiol.3,327–338 (1997).
   Web of Science ®Google Scholar
• Hilden JM, Meerbaum S, Burger P et al. Central nervous system atypical teratoid/rhabdoid tumor: results of therapy in children enrolled in a registry. J. Clin. Oncol.22(14), 2877–2884 (2004).
   PubMed Web of Science ®Google Scholar
• Howes TL, Buatti JM, O’Dorisio MS et al. Atypical teratoid/rhabdoid tumor case report: treatment with surgical excision, radiation therapy and alternative medicine. J. Neurooncol.(72), 85–88 (2005).
   PubMedGoogle Scholar
• Geyer JR, Finlay JL, Boyett JM et al. Survival of infants with malignant astrocytomas. A report from the childrens cancer group. Cancer75(4), 1045–1050 (1995).
   PubMed Web of Science ®Google Scholar
• Kunwar S, Mohapatra G, Bollen A et al. Genetic subgroups of anaplastic astrocytomas correlate with patient age and survival. Cancer Res.1561(20), 7683–7688 (2001).
   Google Scholar
• Pollack IF, Finkelstein SD, Woods J et al. Expression of p53 and prognosis in children with malignat gliomas. N. Engl. Med.7346(6), 420–427 (2002).
   Google Scholar
• Schüller U, Koch A, Hartmann W et al. Subtype-specific expression and genetic alterations of the chemokine receptor gene CXCR4 in medulloblastomas. Int. J. Cancer117, 82–89 (2005).
   PubMed Web of Science ®Google Scholar
• Pomeroy SL, Tamayo P, Gaasenbeek M et al. Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature415, 436–42 (2002).
   PubMed Web of Science ®Google Scholar
• Taylor MD, Poppleton H, Fuller C et al. Radial glia cells are candidate stem cells of ependymoma. Cancer Cell8(4), 323–335 (2005).
   PubMed Web of Science ®Google Scholar